Soleno Therapeutics (SLNO) had the highest return in 2023 by a mid-cap US stock, returning 1,825.8%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 2023 | 1,825.84% |
Applied Opt (AAOI) | 2023 | 895.88% |
Cipher Mining (CIFR) | 2023 | 614.53% |
Olema Pharmaceuticals (OLMA) | 2023 | 465.73% |
CleanSpark (CLSK) | 2023 | 425.24% |
Immunome (IMNM) | 2023 | 345.83% |
Riot Blockchain (RIOT) | 2023 | 343.27% |
Opendoor Technologies (OPEN) | 2023 | 279.66% |
Abercrombie & Fitch (ANF) | 2023 | 279.6% |
Oscar Health (OSCR) | 2023 | 266% |
Terawulf (WULF) | 2023 | 258.21% |
Applied Digital (APLD) | 2023 | 256.61% |
Aurora Innovation (AUR) | 2023 | 244.09% |
Disc Medicine (IRON) | 2023 | 222.68% |
Duolingo (DUOL) | 2023 | 218.92% |
Hut 8 Corp Common Stock (HUT) | 2023 | 212.78% |
Camtek (CAMT) | 2023 | 211.96% |
Archer Aviation (ACHR) | 2023 | 211.68% |
SkyWest (SKYW) | 2023 | 210.9% |
Upstart Holdings (UPST) | 2023 | 200.88% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2023 | 196.1% |
BW LPG (BWLP) | 2023 | 194% |
M/I Homes (MHO) | 2023 | 193.06% |
Galaxy Digital (GLXY) | 2023 | 183.6% |
Structure Therapeutics Inc American Depositary Shares (GPCR) | 2023 | 171.73% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
